- Poster presentation
- Open Access
Non-contrast peripheral angiography at 3T using QISS: improving venous suppression
© Giri et al.; licensee BioMed Central Ltd. 2014
- Published: 16 January 2014
- Magnetic Resonance Angiography
- Digital Subtraction Angiography
- Imaging Parameter
- Siemens Healthcare
- Full Time Employee
Quiescent Interval Single Shot (QISS) has emerged as a robust technique for non-enhanced angiography of peripheral arteries (1). It has been clinically validated with contrast enhanced magnetic resonance angiography (CE-MRA) and digital subtraction angiography (DSA) (2,3). Both of these validation studies were performed at 1.5T field strength. Although the initial experience with QISS at 3T using similar imaging parameters as those at 1.5T were promising, venous suppression was inadequate in the thigh and pelvic regions of some patients (4,5). In this work, we present a strategy to improve venous signal suppression with the QISS sequence at 3T.
The imaging parameters were similar to those reported earlier for QISS at 1.5T (2) with the following exception: the tracking saturation pulse for venous signal attenuation was replaced with an adiabatic inversion pulse (hyperbolic secant). This enables a more homogenous venous suppression at 3T than is possible with regular sinc pulse due to B1 inhomogeneity. The prototype sequence was tested in three volunteers in a 3T system (MAGNETOM Skyra, Siemens Healthcare).
Although QISS has shown robust performance at 1.5T, initial experience at 3T demonstrated suboptimal venous suppression. Although not established, this could be attributed to increased B1 inhomogeneity at 3T. We have demonstrated an approach to improve venous signal suppression at 3T using QISS. More patient studies are required and are underway to test the robustness and consistency of this approach.
The primary author is a full time employee of Siemens Healthcare.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.